Journals / 7tepe Klinik / 2018 / Cilt: 14 - Sayı: 2

Hemostatic agents for pulpotomy treatment in primary teeth

Süt dişi pulpotomi tedavilerinde kullanılan hemostatik ajanlar

Pages
109–116
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The purpose of this paper is to review various hemostatic agents used in pulpotomy treatment in pediatric dentistry practice.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The need for pulpal treatment in the primary teeth is greater than the permanent teeth, because in primary teeth enamel and dentin is thinner, the pulp chamber is relatively wider and pulp horns are closer to the surface than permanent teeth.
📊
Key Findings & Data:Clot formation affects healing as well as it can create a favorable environment for the bacteria to induce inflammation and infection and also decreases the success of the treatment by preventing the pulp tissue- medicament contact.
💡
Conclusion & Impact:The purpose of this paper is to review various hemostatic agents used in pulpotomy treatment in pediatric dentistry practice.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The need for pulpal treatment in the primary teeth is greater than the permanent teeth, because in primary teeth enamel and dentin is thinner, the pulp chamber is relatively wider and pulp horns are closer to the surface than permanent teeth. Pulpotomy is a frequently used method in pediatric dentistry and for the success of the treatment material is an important factor. Clot formation affects healing as well as it can create a favorable environment for the bacteria to induce inflammation and infection and also decreases the success of the treatment by preventing the pulp tissue- medicament contact. Therefore, it is believed that an effective haemostasis, increases treatment success. For these reasons hemostatic agents have begun to be used in pulpotomy treatments. The purpose of this paper is to review various hemostatic agents used in pulpotomy treatment in pediatric dentistry practice.

Özet

Süt dişlerindeki mine ve dentin kalınlığının daimi dişlere göre daha az olması, pulpa odasının daimi dişlere göre göreceli olarak daha geniş olması ve süt dişlerinde pulpa boynuzlarının yüzeye daha yakın olması sebebi ile pulpal tedavi gereksinimi daimi dişlere göre daha fazla görülmektedir. Çocuk diş hekimliğinde pulpotomi tedavisi sıklıkla kullanılan bir yöntemdir ve tedavinin başarısında kullanılan materyal önemli faktörlerden biridir. Pıhtı formasyonu iyileşmeyi olumsuz etkilediği gibi bakteriler için uygun bir ortam oluşturup bölgede enflamasyon ve enfeksiyonu tetikleyebilmekte, ayrıca pulpa dokusu ile üzerine konulan medikamentin temasını engellediği için tedavi başarısını düşürmektedir. Bu yüzden pulpotomi tedavisinde kalan pulpa dokusunda pıhtıyı ortadan kaldıran etkili bir hemostazın tedavinin başarısını artırıcı bir rol oynadığı düşünülmektedir. Bu nedenlerden dolayı hemostatik ajanlar pulpotomi tedavilerinde kullanılmaya başlanmıştır. Bu makalede, çocuk diş hekimliği pratiğinde pulpotomi tedavilerinde kullanılan farklı hemostatik ajanların derlenmesi amaçlanmıştır.

🔖

Cite This Article

DELİKAN, E. (2018). Hemostatic agents for pulpotomy treatment in primary teeth. 7tepe Klinik, Cilt: 14 - Sayı: 2, 109–116. https://ajindex.com/articles/148530

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Fejerskov ONB, Kidd, E.A.M. Clinical and Histologic Manifestations of Dental Caries. Copenhagen: Blackwell Munksgaard; 2003.
  2. Caufield PW, Cutter GR, Dasanayake AP. Initial acquisition of mutans streptococci by infants: evidence for a discrete window of infectivity. J Dent Res 1993; 72: 37-45.
  3. Fuks ABKA, Guelmann, M. Pulp Therapy for the Primary Dentition Pediatric Dentistry Infancy Through Adolescence. Elsevier Saunders: St. Louis, Missouri; 2013.
  4. Simancas-Pallares MA, Diaz-Caballero AJ, Luna-Ricardo LM. Mineral trioxide aggregate in primary teeth pulpotomy. A systematic literature review. Med Oral Patol Oral Cir Bucal 2010; 15: e942-946. Nadin G, Goel BR, Yeung CA, Glenny AM. Pulp treatment for extensive decay in primary teeth. Cochrane Database Syst Rev 2003:CD003220. Pinkham JR. Pediatric Dentistry: Infancy Through Adolescence. Philadelphia: W.B.Saunders Company; 1999.
  5. Dean JA, Mack RB, Fulkerson BT, Sanders BJ. Comparison of electrosurgical and formocresol pulpotomy procedures in children. Int J Paediatr Dent 2002; 12: 177-182.
  6. Liu JF, Chen LR, Chao SY. Laser pulpotomy of primary teeth. Pediatr Dent 1999; 21: 128-129.
  7. Ansari G, Ranjpour M. Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year follow-up. Int Endod J 2010; 43: 413-418.
  8. Fuks AB, Bimstein E, Guelmann M, Klein H. Assessment of a 2 percent buffered glutaraldehyde solution in pulpotomized primary teeth of schoolchildren. ASDC J Dent Child 1990; 57: 371-375.
  9. Ibricevic H, Al-Jame Q. Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow-up study. Eur J Paediatr Dent 2003; 4: 28-32. Nakashima M. Induction of dentin formation on canine amputated pulp by recombinant human bone morphogenetic proteins (BMP)-2 and -4. J Dent Res 1994; 73: 1515-1522.
  10. Asgary S, Ahmadyar M. Vital pulp therapy using calcium-enriched mixture: An evidence-based review. J Conserv Dent 2013; 16: 92-98.
  11. Yaman E, Gorken F, Pinar Erdem A, Sepet E, Aytepe Z. Effects of folk medicinal plant extract Ankaferd Blood Stopper((R)) in vital primary molar pulpotomy. Eur Arch Paediatr Dent 2012; 13: 197-202.
  12. Odabas ME, Cinar C, Tulunoglu O, Isik B. A new haemostatic agent's effect on the success of calcium hydroxide pulpotomy in primary molars. Pediatr Dent 2011; 33: 529-534.
  13. Lewis BB, Chestner SB. Formaldehyde in dentistry: a review of mutagenic and carcinogenic potential. J Am Dent Assoc 1981; 103: 429-434. Milnes AR. Is formocresol obsolete? A fresh look at the evidence concerning sa